Oligonucleotide CDMO · RNA therapeutic ingredients · Small-molecule APIs
ST Pharm
A CDMO producing oligonucleotide active ingredients, ranked among global leaders in contract manufacturing for RNA therapeutics. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Biopharma Manufacturing & CDMO · Biopharma & Life Sciences · primary
Other companies in the same category
- Biopharma Manufacturing & CDMO: Fujifilm Holdings · Samsung Biologics · WuXi AppTec · WuXi Biologics · Thermo Fisher Scientific
237690.KQ Updated Jul 11, 2026 3 AI consumers· 3 recurring
Annual return · 2026-09-04'21+19.5%'22-22.5%'23-23.2%'24+41%'25+83.9%YTD-36.4%
Money in ▸·
ST Pharm
▸ Money out·
Financials & Segments
- Segments · Oligonucleotide CDMO · Small-molecule API · Own drug pipeline
Revenue from
No refined links yet.
Pays to
No refined links yet.